person · Reporting owner
KRAEMER HARRY M JANSEN JR
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 12, 2024 | January 16, 2024 |
| Leidos Holdings, Inc.LDOS · Entity 668 | Director | October 07, 2026 | October 09, 2026 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 12, 2024 · Filed January 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,351.467 |
Reported balance
After 2024-01-12 transaction · row 1
1 source rowRow 1 · 2024-01-12 · Grant · Acquired 46.076 · Balance 148,351.467 F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 2,758.1977 |
Reported balance
After 2024-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-12 · Grant · Acquired 10.4546 · Balance 2,758.1977 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Leidos Holdings, Inc.
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Key Executive Stock Deferral Plan | 132,108.0146 |
Reported balance
After 2026-10-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 297.2259 · Balance 132,108.0146 F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. |
| Common StockSEC Table I · non-derivative | Direct | 93,281 |
Reported balance
Holding disclosure · report date 2026-10-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 93,281 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 471,076 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 458,997 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 12,079 · Balance 471,076 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VWR Corp
Report date November 21, 2017 · Filed November 22, 2017
Section 16 reporting ended · disclosed 2017-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 1
1 source rowRow 1 · 2017-11-21 · Disposition to issuer · Disposed 7,617 · Balance 0 F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. |
| Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.00 · Expires 2021-10-01 | Direct | 0 |
Reported balance
After 2017-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-11-21 · Disposition to issuer · Disposed 22,617 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.
F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 9, 2026 20:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 297.2259 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000287 · wk-form4_1791576694.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 132,108.0146 F1 · shares: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:30 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 463.0695 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000277 · wk-form4_1790973014.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 131,810.7887 F1 · shares: Dividend equivalent rights. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 22:06 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 310.4305 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000242 · wk-form4_1783462009.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 131,347.7192 F1 · shares: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:24 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 565.1218 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000238 · wk-form4_1783023862.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 131,037.2887 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 20, 2026 Filed May 22, 2026 22:07 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 12,079 | $22.23 | $268,516.17 |
DisclosureSEC source: 0001437749-26-018301 · rdgdoc.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,076 F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. Read SEC document |
| May 20, 2026 Filed May 22, 2026 22:07 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 8,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-018301 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,997 F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Read SEC document |
| May 08, 2026 Filed May 12, 2026 12:56 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,281 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001336920-26-000210 · wk-form4_1778590577.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,281 Underlying: Common Stock · 1,281 shares Expires 2033-05-07 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 08, 2026 Filed May 12, 2026 12:56 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000210 · wk-form4_1778590577.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 130,472.1669 Read SEC document |
| May 04, 2026 Filed May 5, 2026 21:32 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 36,610 | $21.41 | $783,772.51 |
DisclosureSEC source: 0001437749-26-014959 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 F1 · price: Reflects the weighted average price of 36,610 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.35 to $21.475 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:34 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 9.7117 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000172 · wk-form4_1778013257.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 129,405.1669 F1 · shares: Dividend equivalent rights. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 220.7614 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000161 · wk-form4_1776202385.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 129,395.4552 F1 · shares: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:57 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 363.5515 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000152 · wk-form4_1775163428.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 129,174.6938 F1 · shares: Dividend equivalent rights. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,345 | $0.00 Strike: $75.02 | $0.00 |
DisclosureSEC source: 0001336920-26-000068 · wk-form4_1771969127.xml · derivative · entry 4 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,345 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 1,424 | $176.27 | $251,008.48 |
DisclosureSEC source: 0001336920-26-000068 · wk-form4_1771969127.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,281 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:38 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 3,345 | $75.02 | $250,941.90 |
DisclosureSEC source: 0001336920-26-000068 · wk-form4_1771969127.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:29 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 171.6596 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000018 · wk-form4_1767994182.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 128,811.1423 F1 · shares: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 22:14 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 305.0167 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-26-000012 · wk-form4_1767392073.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 128,639.4827 F1 · shares: Dividend equivalent rights. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:30 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 38,000 | $25.98 | $987,392.00 |
DisclosureSEC source: 0001437749-25-033040 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,390 F1 · price: Reflects the weighted average price of 38,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 3, 2025 with purchase prices ranging from $25.835 to $26.235 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 20:32 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 164.9746 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-25-000052 · wk-form4_1760041971.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 128,334.466 F1 · shares: The reporting person elected to defer receipt of these shares, which represent a quarterly payment of their retainer for service on the company's Board of Directors, under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:50 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 279.3241 | $0.00 | $0.00 |
DisclosureSEC source: 0001336920-25-000050 · wk-form4_1759438216.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 128,169.4914 F1 · shares: Dividend equivalent rights. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 22:25 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 36,000 | $27.15 | $977,277.60 |
DisclosureSEC source: 0001437749-25-027536 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,390 F1 · price: Reflects the weighted average price of 36,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $26.92 to $27.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 20:45 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 200.5059 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-034739 · wk-form4_1752180296.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 127,890.1673 F1 · shares: The reporting person elected to defer receipt of their quarterly retainer for service on the company's Board of Directors under the terms of the Leidos Holdings, Inc. Key Executive Stock Deferral Plan. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:22 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 331.6128 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-033998 · wk-form4_1751487718.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 127,689.6614 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 8,022 | $31.79 | $255,019.38 |
DisclosureSEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,390 F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,368 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:57 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,030 | $0.00 Strike: $154.71 | $0.00 |
DisclosureSEC source: 0001628280-25-025176 · wk-form4_1747169860.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,030 Underlying: Common Stock · 1,030 shares Expires 2032-05-08 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of stockholders of the Company is concluded. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:57 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-025176 · wk-form4_1747169860.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 127,358.0486 Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 20:33 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 253.9503 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-017201 · wk-form4_1744230815.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 126,485.0486 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 375.972 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-015930 · wk-form4_1743540145.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 126,231.0983 F1 · shares: Dividend equivalent rights. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:16 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,070 | $0.00 Strike: $63.08 | $0.00 |
DisclosureSEC source: 0001628280-25-007842 · wk-form4_1740521758.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,070 shares Expires 2025-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 22:16 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 4,070 | $63.08 | $256,735.60 |
DisclosureSEC source: 0001628280-25-007842 · wk-form4_1740521758.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 21:11 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 214.4082 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-001133 · wk-form4_1736543486.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 125,855.1263 F1 · shares: Dividend equivalent rights. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:40 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 354.7544 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-000305 · wk-form4_1735940428.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 125,640.7181 F1 · shares: Dividend equivalent rights. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 22:27 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 43,000 | $22.54 | $969,030.80 |
DisclosureSEC source: 0001437749-24-034978 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,334 F1 · price: Reflects the weighted average price of 43,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 8, 2024 with purchase prices ranging from $22.265 to $23.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 27, 2024 Filed Oct 1, 2024 20:39 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 303.749 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-041744 · wk-form4_1727815144.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 125,285.9637 F1 · shares: Dividend equivalents. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 326.1695 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-030845 · wk-form4_1719952945.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 124,982.2147 F1 · shares: Dividend equivalent rights. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:57 UTC | Option Care Health, Inc. OPCH · Entity 4126 | GrantCommon Stock | 13,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017513 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,334 F1 · shares: The reporting person received an award of restricted stock units on May 15, 2024, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $415,000 of value based on the closing price of the issuer's common stock on May 15, 2024. Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:02 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 1,179 | $0.00 Strike: $142.66 | $0.00 |
DisclosureSEC source: 0001628280-24-021229 · wk-form4_1715119322.xml · derivative · entry 3 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179 Underlying: Common Stock · 1,179 shares Expires 2031-05-02 F1 · derivative.exercise_date: The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded. Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:02 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 912 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-021229 · wk-form4_1715119322.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 124,656.0452 Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:18 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,788 | $0.00 Strike: $52.70 | $0.00 |
DisclosureSEC source: 0001628280-24-020304 · wk-form4_1714767488.xml · derivative · entry 4 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,788 shares Expires 2024-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:18 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 1,775 | $142.19 | $252,387.25 |
DisclosureSEC source: 0001628280-24-020304 · wk-form4_1714767488.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,290 F1 · kind: Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees. Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:18 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Exercise / conversionCommon Stock | 4,788 | $52.70 | $252,327.60 |
DisclosureSEC source: 0001628280-24-020304 · wk-form4_1714767488.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 21:39 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 17.9359 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-019417 · wk-form4_1714513163.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 123,744.0452 F1 · shares: Dividend equivalent rights. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:13 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 362.0583 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-014120 · wk-form4_1712005989.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 123,726.1093 F1 · shares: Dividend equivalent rights. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:41 UTC | Option Care Health, Inc. OPCH · Entity 4126 | PurchaseCommon Stock | 35,000 | $31.55 | $1,104,351.50 |
DisclosureSEC source: 0001437749-24-005910 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,528 F1 · price: Reflects the weighted average price of 35,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on February 26, 2024 with purchase prices ranging from $31.515 to $31.58 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 18:58 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 10.4546 | $36.80 | $384.73 |
DisclosureSEC source: 0001127602-24-001314 · form4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,758.1977 Underlying: Common Stock · 10.4546 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 18:58 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 46.076 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001314 · form4.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,351.467 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 22:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 702.7117 | $35.58 | $25,002.48 |
DisclosureSEC source: 0001127602-24-000157 · form4.xml · derivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,747.7431 Underlying: Common Stock · 702.7117 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 22:10 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantCommon Stock | 436.3287 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000254 · wk-form4_1704319797.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Key Executive Stock Deferral Plan Disclosed balance after: 123,364.051 F1 · shares: Dividend equivalent rights. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 21:01 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative | 9.2809 | $30.71 | $285.02 |
DisclosureSEC source: 0001127602-23-025914 · form4.xml · derivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,045.0314 Underlying: Common Stock · 9.2809 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.